Ọrịa prostate dị elu na-esonyere ọtụtụ metastases ọkpụkpụ-05

Achọpụtara onye ọrịa ahụ, nwoke dị afọ 67 na ọrịa kansa prostate dị elu na-esonyere ọtụtụ metastases ọkpụkpụ. Nchọpụta mbụ gosiri na etuto ahụ na-akpa ike nke ukwuu na enweghị ike iwepụ ya kpamkpam na ịwa ahụ. N'agbanyeghị na a na-ana ya radieshon na chemotherapy, etuto ahụ gara n'ihu na-agbasa na anụ ahụ gbara ya gburugburu ma meghachi omume na-adịghị mma na ọgwụgwọ.

N'iburu njedebe nke ọgwụgwọ ọdịnala na ọnọdụ ahụike onye ọrịa, ọ họọrọ isonye na nyocha ụlọ ọgwụ maka ọgwụgwọ cell NK (Natural Killer). Atụmatụ ọgwụgwọ malitere na usoro izizi na February 2023, na-esote ọgwụgwọ mmezi kwa ọnwa isii. Oge nke ọ bụla gụnyere mweghachi nke mkpụrụ ndụ na-alụso ọrịa ọgụ site na infusion intravenous iji kwalite usoro ahụ ji alụso ọrịa ọgụ n'ịlụso etuto ahụ ọgụ.

Mgbe usoro ọgwụgwọ mbụ nke NK cell therapy gasịrị, onye ọrịa ahụ kọrọ ihe ịrịba ama mbụ nke mgbu mgbu na mma ndụ. Akara arụmọrụ anụ ahụ ya mụbara, ọnọdụ uche ya gosipụtara mmụba dị ukwuu.

Mgbe usoro ọgwụgwọ nke abụọ gasịrị, a na-eme nyocha nyocha PET-CT. Nsonaazụ nyocha ahụ gosipụtara mbelata dị ukwuu na ọrụ metabolic na ma ụbụrụ prostate bụ isi na metastases ọkpụkpụ, yana ọnya ụfọdụ na-egosi nlọghachi azụ zuru oke. A na-ebelata ibu nke tumor nke ọma, na-akwado ịdị irè nke ọgwụgwọ ahụ.

Ka ọ dị ugbu a, ndụ onye ọrịa abawanyela nke ukwuu, a na-ejikwa akara ngosi ya nke ọma n'enweghị ihe ịrịba ama nke nlọghachite tumor mpaghara. Ọ na-aga n'ihu na-aga n'ihu na-ahụ maka nlekọta na nlekọta ọgwụgwọ mgbe niile iji hụ na ịdị irè na-aga n'ihu na ọganihu nke ọnọdụ ya.

N'ịkwado usoro ọgwụgwọ NK cell, ọnọdụ onye ọrịa abawanyela nke ọma, na-enye nkwado siri ike na agbamume maka nyocha ọzọ na ntinye nke immunotherapy na ndị ọrịa cancer prostate.